113 related articles for article (PubMed ID: 12921881)
1. Arachidonic acid in mononuclear cells and its clinical significance in HCV cirrhotic patients.
Okita M; Tomioka K; Ota Y; Sasagawa T; Osawa T; Sakai N; Kawaguchi M; Itoshima T
Nutrition; 2003 Sep; 19(9):727-32. PubMed ID: 12921881
[TBL] [Abstract][Full Text] [Related]
2. Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions.
Yaqoob P; Pala HS; Cortina-Borja M; Newsholme EA; Calder PC
Eur J Clin Invest; 2000 Mar; 30(3):260-74. PubMed ID: 10692004
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid composition of the erythrocyte membrane and risk of hepatocellular carcinoma in cirrhotic patients.
Mouillot T; Rizk M; Pais de Barros JP; Gilloteau A; Busson A; Bernard-Chabert B; Thiefin G; Barraud H; Bronowicki JP; Richou C; Di Martino V; Doffoel M; Minello A; Latournerie M; Jouve JL; Brondel L; Brindisi MC; Petit JM; Hillon P; Cottet V;
Aliment Pharmacol Ther; 2020 Nov; 52(9):1503-1515. PubMed ID: 32780481
[TBL] [Abstract][Full Text] [Related]
4. Identification of candidate biomarkers for hepatocellular carcinoma in plasma of HCV-infected cirrhotic patients by 2-D DIGE.
Ferrín G; Ranchal I; Llamoza C; Rodríguez-Perálvarez ML; Romero-Ruiz A; Aguilar-Melero P; López-Cillero P; Briceño J; Muntané J; Montero-Álvarez JL; De la Mata M
Liver Int; 2014 Mar; 34(3):438-46. PubMed ID: 23944848
[TBL] [Abstract][Full Text] [Related]
5. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC.
Helaly GF; Abou Shamaa LA
Egypt J Immunol; 2006; 13(1):27-38. PubMed ID: 17974148
[TBL] [Abstract][Full Text] [Related]
6. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of serum galectin-3 levels in patients with hepatocellular cancer and chronic viral hepatitis.
Ulu M; Alacacioglu A; Yuksel E; Pamukk BO; Bozkaya G; Ari A; Yuksel A; Sop G; Alacacioglu I
Saudi J Gastroenterol; 2015; 21(1):47-50. PubMed ID: 25672239
[TBL] [Abstract][Full Text] [Related]
8. Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.
Fitian AI; Nelson DR; Liu C; Xu Y; Ararat M; Cabrera R
Liver Int; 2014 Oct; 34(9):1428-44. PubMed ID: 24661807
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of linseed oil and different doses of fish oil on mononuclear cell function in healthy human subjects.
Wallace FA; Miles EA; Calder PC
Br J Nutr; 2003 May; 89(5):679-89. PubMed ID: 12720588
[TBL] [Abstract][Full Text] [Related]
10. Plasma nitrites/nitrates in HCV infection and hepatocellular carcinoma.
Moussa YI; Plevris JN; Hayes PC
Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):159-63. PubMed ID: 10741929
[TBL] [Abstract][Full Text] [Related]
11. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of elderly hepatitis C virus-associated hepatocellular carcinoma patients.
Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Tada T; Tanaka J
J Gastroenterol Hepatol; 2013 Feb; 28(2):357-64. PubMed ID: 23190084
[TBL] [Abstract][Full Text] [Related]
13. Detection of MAGE-4 protein in the sera of patients with hepatitis-C virus-associated hepatocellular carcinoma and liver cirrhosis.
Tsuzurahara S; Sata M; Iwamoto O; Shichijo S; Kojiro M; Tanikawa K; Itoh K
Jpn J Cancer Res; 1997 Sep; 88(9):915-8. PubMed ID: 9369941
[TBL] [Abstract][Full Text] [Related]
14. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.
Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA
World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667
[TBL] [Abstract][Full Text] [Related]
15. Plasma protein biomarkers of hepatocellular carcinoma in HCV-infected alcoholic patients with cirrhosis.
Ferrín G; Rodríguez-Perálvarez M; Aguilar-Melero P; Ranchal I; Llamoza C; Linares CI; González-Rubio S; Muntané J; Briceño J; López-Cillero P; Montero-Álvarez JL; de la Mata M
PLoS One; 2015; 10(3):e0118527. PubMed ID: 25789864
[TBL] [Abstract][Full Text] [Related]
16. Serum transforming growth factor alpha level as a marker of hepatocellular carcinoma complicating cirrhosis.
Tomiya T; Fujiwara K
Cancer; 1996 Mar; 77(6):1056-60. PubMed ID: 8635123
[TBL] [Abstract][Full Text] [Related]
17. Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma.
Alkozai EM; Porte RJ; Adelmeijer J; Zanetto A; Simioni P; Senzolo M; Lisman T
Platelets; 2015; 26(6):577-82. PubMed ID: 25275728
[TBL] [Abstract][Full Text] [Related]
18. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population.
Tanaka K; Hirohata T; Koga S; Sugimachi K; Kanematsu T; Ohryohji F; Nawata H; Ishibashi H; Maeda Y; Kiyokawa H
Cancer Res; 1991 Jun; 51(11):2842-7. PubMed ID: 1851661
[TBL] [Abstract][Full Text] [Related]
20. Increased serum concentrations of tumor necrosis factor-alpha are associated with disease progression and malnutrition in hepatocellular carcinoma.
Wang YY; Lo GH; Lai KH; Cheng JS; Lin CK; Hsu PI
J Chin Med Assoc; 2003 Oct; 66(10):593-8. PubMed ID: 14703276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
